1. Home
  2. LSTA vs DTST Comparison

LSTA vs DTST Comparison

Compare LSTA & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • DTST
  • Stock Information
  • Founded
  • LSTA 1980
  • DTST 2001
  • Country
  • LSTA United States
  • DTST United States
  • Employees
  • LSTA N/A
  • DTST N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • DTST EDP Services
  • Sector
  • LSTA Health Care
  • DTST Technology
  • Exchange
  • LSTA Nasdaq
  • DTST Nasdaq
  • Market Cap
  • LSTA 24.2M
  • DTST 28.5M
  • IPO Year
  • LSTA N/A
  • DTST N/A
  • Fundamental
  • Price
  • LSTA $2.85
  • DTST $3.72
  • Analyst Decision
  • LSTA Strong Buy
  • DTST
  • Analyst Count
  • LSTA 1
  • DTST 0
  • Target Price
  • LSTA $15.00
  • DTST N/A
  • AVG Volume (30 Days)
  • LSTA 15.2K
  • DTST 75.3K
  • Earning Date
  • LSTA 11-12-2024
  • DTST 11-14-2024
  • Dividend Yield
  • LSTA N/A
  • DTST N/A
  • EPS Growth
  • LSTA N/A
  • DTST N/A
  • EPS
  • LSTA N/A
  • DTST 0.02
  • Revenue
  • LSTA N/A
  • DTST $25,143,911.00
  • Revenue This Year
  • LSTA N/A
  • DTST $8.30
  • Revenue Next Year
  • LSTA N/A
  • DTST $11.32
  • P/E Ratio
  • LSTA N/A
  • DTST $184.79
  • Revenue Growth
  • LSTA N/A
  • DTST 1.64
  • 52 Week Low
  • LSTA $2.05
  • DTST $2.75
  • 52 Week High
  • LSTA $3.83
  • DTST $8.00
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 46.05
  • DTST 47.50
  • Support Level
  • LSTA $2.75
  • DTST $3.35
  • Resistance Level
  • LSTA $2.94
  • DTST $5.20
  • Average True Range (ATR)
  • LSTA 0.21
  • DTST 0.34
  • MACD
  • LSTA -0.01
  • DTST 0.06
  • Stochastic Oscillator
  • LSTA 23.08
  • DTST 20.00

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

Share on Social Networks: